223 related articles for article (PubMed ID: 6996685)
1. Effects of phenobarbital and beta-naphthoflavone on the activation of cyclophosphamide to mutagenic metabolites in vitro by liver and kidney from male and female rats.
Hales BF; Jain R
Biochem Pharmacol; 1980 Jul; 29(14):2031-7. PubMed ID: 6996685
[No Abstract] [Full Text] [Related]
2. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
Hales BF
Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the activation of cyclophosphamide to a mutagen by rat liver.
Hales BF; Jain R
Biochem Pharmacol; 1980 Feb; 29(2):256-9. PubMed ID: 6767482
[No Abstract] [Full Text] [Related]
4. Mutagenic activation of 2,4-diaminoanisole and 2-amino-fluorene by isolated rat liver nuclei and microsomes.
Aune T; Dybing E; Nelson SD
Chem Biol Interact; 1980 Jul; 31(1):35-49. PubMed ID: 6993025
[No Abstract] [Full Text] [Related]
5. Effects of phenobarbital, 3-methylcholanthrene and beta-naphthoflavone pretreatment on mouse liver microsomal enzymes and on metabolite patterns of benzo[a]pyrene.
Wang IY
Biochem Pharmacol; 1981 Jun; 30(11):1337-43. PubMed ID: 6268094
[No Abstract] [Full Text] [Related]
6. Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes.
Yamazaki H; Mimura M; Oda Y; Inui Y; Shiraga T; Iwasaki K; Guengerich FP; Shimada T
Carcinogenesis; 1993 Jul; 14(7):1271-8. PubMed ID: 8330339
[TBL] [Abstract][Full Text] [Related]
7. Influence of Aroclor 1254, phenobarbital, beta-naphthoflavone, and ethanol pretreatment on the biotransformation of cyclophosphamide in male and female rats.
Sessink PJ; Vaes WH; van den Broek PH; de Roos JH; Noordhoek J; Bos RP
Toxicology; 1996 Aug; 112(2):141-50. PubMed ID: 8814343
[TBL] [Abstract][Full Text] [Related]
8. Aging modifies the expression of hepatic microsomal cytochromes P-450 after pretreatment of rats with beta-naphthoflavone or phenobarbital.
Sun JQ; Lau PP; Strobel HW
Exp Gerontol; 1986; 21(2):65-73. PubMed ID: 3758228
[TBL] [Abstract][Full Text] [Related]
9. Differences in the effects of model inducers of cytochrome P450 on the biotransformation of scoparone in rat and hamster liver.
Mennes WC; Luijckx NB; Wortelboer HM; Noordhoek J; Blaauboer BJ
Arch Toxicol; 1993; 67(2):92-7. PubMed ID: 8481107
[TBL] [Abstract][Full Text] [Related]
10. Activation of 6-aminochrysene to genotoxic products by different forms of rat liver cytochrome P450 in an O-acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).
Yamazaki H; Shimada T
Biochem Pharmacol; 1992 Sep; 44(5):913-20. PubMed ID: 1530660
[TBL] [Abstract][Full Text] [Related]
11. Immunological and enzymatic comparison of hepatic cytochrome P-450 fractions from phenobarbital-, 3-methylcholanthrene-, beta-naphthoflavone- and 2,3,7,8- tetrachlorodibenzo-p-dioxin-treated rats.
le Provost E; Cresteil T; Columelli S; Leroux JP
Biochem Pharmacol; 1983 Jun; 32(11):1673-82. PubMed ID: 6870906
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 induction and mutagenicity of 2-aminoanthracene (2AA) in rat liver and gut.
Carrière V; de Waziers I; Courtois YA; Leroux JP; Beaune PH
Mutat Res; 1992 Jul; 268(1):11-20. PubMed ID: 1378177
[TBL] [Abstract][Full Text] [Related]
13. Effects of 3-methylcholanthrene, beta-naphthoflavone, and phenobarbital on the 3-methylcholanthrene-inducible isozyme of cytochrome P-450 within centrilobular, midzonal, and periportal hepatocytes.
Baron J; Redick JA; Guengerich FP
J Biol Chem; 1982 Jan; 257(2):953-7. PubMed ID: 7054190
[No Abstract] [Full Text] [Related]
14. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
Hellmold H; Overvik E; Strömstedt M; Gustafsson JA
Carcinogenesis; 1993 Sep; 14(9):1751-7. PubMed ID: 8403195
[TBL] [Abstract][Full Text] [Related]
15. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
Mays DC; Hilliard JB; Wong DD; Chambers MA; Park SS; Gelboin HV; Gerber N
J Pharmacol Exp Ther; 1990 Aug; 254(2):720-31. PubMed ID: 2117068
[TBL] [Abstract][Full Text] [Related]
16. Activation and inactivation of a variety of mutagenic compounds by the reconstituted system containing highly purified preparations of cytochrome P-450 from rat liver.
Kawano S; Kamataki T; Maeda K; Kato R; Nakao T; Mizoguchi I
Fundam Appl Toxicol; 1985 Jun; 5(3):487-98. PubMed ID: 3924696
[TBL] [Abstract][Full Text] [Related]
17. Multiple effects and metabolism of alpha-naphthoflavone in induced and uninduced hepatic microsomes.
Nesnow S
Basic Life Sci; 1983; 24():313-29. PubMed ID: 6860268
[No Abstract] [Full Text] [Related]
18. Influence of age, phenobarbital and beta-naphthoflavone on hepatic microsomal lipid peroxidation in rats.
Jahn F; Karge E; Klinger W
Z Versuchstierkd; 1990; 33(3):140-5. PubMed ID: 2402955
[TBL] [Abstract][Full Text] [Related]
19. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
Bornheim LM; Franklin MR
Mol Pharmacol; 1982 Mar; 21(2):527-32. PubMed ID: 7099151
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of alpha-naphthoflavone and beta-naphthoflavone by rat liver microsomes and highly purified reconstituted cytochrome P-450 systems.
Vyas KP; Shibata T; Highet RJ; Yeh HJ; Thomas PE; Ryan DE; Levin W; Jerina DM
J Biol Chem; 1983 May; 258(9):5649-59. PubMed ID: 6853538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
